US20210401348A1 - Signal color morphology - Google Patents
Signal color morphology Download PDFInfo
- Publication number
- US20210401348A1 US20210401348A1 US17/468,296 US202117468296A US2021401348A1 US 20210401348 A1 US20210401348 A1 US 20210401348A1 US 202117468296 A US202117468296 A US 202117468296A US 2021401348 A1 US2021401348 A1 US 2021401348A1
- Authority
- US
- United States
- Prior art keywords
- scale
- display
- values
- signal
- color
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000012545 processing Methods 0.000 claims description 15
- 238000005259 measurement Methods 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims 3
- 230000008859 change Effects 0.000 abstract description 13
- 239000003086 colorant Substances 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 3
- 238000002565 electrocardiography Methods 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 9
- 238000002679 ablation Methods 0.000 description 7
- 230000000747 cardiac effect Effects 0.000 description 7
- 238000013500 data storage Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002001 electrophysiology Methods 0.000 description 4
- 230000007831 electrophysiology Effects 0.000 description 4
- 230000028161 membrane depolarization Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 210000005242 cardiac chamber Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003601 intercostal effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002336 repolarization Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000016216 Choristoma Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000013144 data compression Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000001615 p wave Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000000718 qrs complex Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/321—Accessories or supplementary instruments therefor, e.g. cord hangers
- A61B5/322—Physical templates or devices for measuring ECG waveforms, e.g. electrocardiograph rulers or calipers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/339—Displays specially adapted therefor
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
- G06F3/14—Digital output to display device ; Cooperation and interconnection of the display device with other functional units
- G06F3/147—Digital output to display device ; Cooperation and interconnection of the display device with other functional units using display panels
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09G—ARRANGEMENTS OR CIRCUITS FOR CONTROL OF INDICATING DEVICES USING STATIC MEANS TO PRESENT VARIABLE INFORMATION
- G09G5/00—Control arrangements or circuits for visual indicators common to cathode-ray tube indicators and other visual indicators
- G09G5/02—Control arrangements or circuits for visual indicators common to cathode-ray tube indicators and other visual indicators characterised by the way in which colour is displayed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/333—Recording apparatus specially adapted therefor
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09G—ARRANGEMENTS OR CIRCUITS FOR CONTROL OF INDICATING DEVICES USING STATIC MEANS TO PRESENT VARIABLE INFORMATION
- G09G2340/00—Aspects of display data processing
- G09G2340/04—Changes in size, position or resolution of an image
- G09G2340/045—Zooming at least part of an image, i.e. enlarging it or shrinking it
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09G—ARRANGEMENTS OR CIRCUITS FOR CONTROL OF INDICATING DEVICES USING STATIC MEANS TO PRESENT VARIABLE INFORMATION
- G09G2380/00—Specific applications
- G09G2380/08—Biomedical applications
Definitions
- the present invention relates to presentation of signals for interpretation, and more particularly to presentation of signals for interpretation by medical personnel.
- the present system allows for the physician to change the relative height of the signal to allow for examination of details of the signals, while maintaining an ability to interpret signal voltage levels absolutely based on color or other secondary mechanism beyond signal height.
- the disclosed system and method provide for faster and more accurate analysis based upon the color of the signal.
- the signal height may change, such as to view, display, or examine details of the signal, while the colors of the display do not.
- the color scale of the signal provides an absolute scaling of the signal regardless of the displayed height.
- a system and method of for displaying measured signal for a device includes monitoring signals in the device, displaying signals on a display, the signals being at least a subset of the monitored signals, controlling a first voltage display level to provide display of at least one displayed measured signals with a height designed to examine details of the measured signal, and providing a second scale to the entirety of the signals displayed independent of the first voltage display level.
- FIG. 1 illustrates a block diagram of a device that may be used in conjunction with or provide feedback to the system described herein;
- FIG. 2 illustrates several plots of the signal voltages of the device of FIG. 2 ;
- FIG. 3 illustrates a depiction of a display screen of the device of FIG. 1 ;
- FIG. 4 illustrates a method of display for the device of FIG. 1 .
- Cardiac electrophysiology is the science of elucidating, diagnosing, and treating the electrical activities of the heart.
- One medical system that is used in this area is the CARTO system.
- cardiac electrophysiology may be used to treat arrhythmias by ablating tissue surrounding the heart that is either the source of unwanted beats or conducts unwanted signals. After treatment, the ablation results in a denaturing of the tissue preventing the tissue from conducting the unwanted signals or beats.
- Electrocardiography is the process of recording the electrical activity of the heart over a period of time using electrodes placed on the skin, or inside the heart using a specialized catheter (i.e. intracardiac ECG). These electrodes detect the small electrical changes that arise from the cardiac muscle's electro-physiologic pattern of depolarizing during each heartbeat. ECGs are commonly or routinely performed cardiology tests. The machine used in the test is an electrocardiograph and the initial output is an electrocardiogram. For the sake of brevity, electrocardiography, electrocardiograph, and electrocardiogram are all referred to herein as ECG, and may also be referred to as EKG.
- An intracardiac electrogram is an ECG with some added intracardiac leads (i.e., inside the heart).
- Such an ICEG may be utilized in combination with, or in the alternative to, a conventional 12-lead ECG.
- a conventional 12-lead ECG 10 electrodes are placed on the patient's limbs and on the surface of the chest.
- the overall magnitude of the electrical potential of the heart is then measured from 12 different angles (“leads”) and is recorded over a period of time.
- the procedure duration may vary from tens of minutes to several hours. During each procedure, there are usually several dozens of ablation sessions, each of which may last several seconds up to approximately 1 minute, for example.
- a conventional 12-lead ECG may be performed over a period of time, such as 10 seconds, for example.
- a period of time such as 10 seconds
- the overall magnitude and direction of the electrical depolarization of the heart is captured at each moment throughout the cardiac cycle.
- a graph of voltage versus time produced by this medical procedure is referred to as an electrocardiogram.
- an ECG conveys a large amount of information about the structure of the heart and the function of its electrical conduction system.
- an ECG can be used to measure the rate and rhythm of heartbeats, the size and position of the heart chambers, the presence of any damage to the muscle cells or conduction system of the heart, the effects of cardiac drugs, and the function of implanted pacemakers.
- Interpretation of the ECG is fundamentally about understanding the electrical conduction system of the heart. Normal conduction starts and propagates in a predictable pattern, and deviation from this pattern can be a normal variation or be pathological.
- cardiac electrophysiology is the science of diagnosing and treating the electrical activities of the heart using, among other techniques, the ECG.
- the term is usually used to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation (PES). These studies are performed to assess complex arrhythmias, elucidate symptoms, evaluate abnormal electrocardiograms, assess risk of developing arrhythmias in the future, and design treatment.
- Therapeutic methods include ablations.
- Ablation generally refers to the removal, killing or scarring of biological tissue, such as to alter the contraction patterns, usually by surgery, and may include methods of ablating aberrant tissue from within the body via minimally invasive procedures.
- FIG. 1 illustrates a block diagram of a device 100 that may be used in conjunction with or provide feedback to the system described herein.
- Device 100 may take the form of an ECG.
- Device 100 includes a series of leads 110 that taper into a single multiplexed input 115 .
- the series of leads 110 may be placed on a human test subject 105 .
- Additional leads 107 which may be included with series of leads 110 , or separate therefrom (as shown) may be intracardiac leads 107 .
- Intracardiac leads 107 may be used for diagnostic or therapeutic treatment, such as for mapping electrical potentials in a heart 126 of a patient 105 .
- intracardiac leads 107 may be used, mutatis mutandis, for other therapeutic and/or diagnostic purposes in the heart or in other body organs.
- Intracardiac leads 107 may be inserted in the vascular system of the patient 105 so that a distal end 132 of the leads 107 enters a chamber of the patient's heart 126 .
- FIG. 1 shows a single lead 107 with a single location sensor, embodiments of the present invention may utilize probes with more than one location sensor.
- the signals on the series of leads 110 are input into an analog front-end 125 via an input multiplexor 120 .
- the analog front-end 125 provides to and is controlled by a processor 130 .
- Processor 130 may include, as shown, a video controller 135 , digital signal processor 140 , a microprocessor 145 , and a micro controller 150 .
- Processor 130 is coupled to a data storage 155 .
- Data ports and printers 160 may be coupled to processor 130 .
- Other input/output devices 165 may be coupled to processor 130 .
- a display 170 may be used to provide output of the signals of the ECG.
- a power/battery management system 175 may be included to provide power for device 100 to operate.
- Series of leads 110 includes both the generally used forms of electrodes and leads.
- One or more of the series of leads 110 may include an ablation electrode the details of which will be described in more detail herein.
- the series of leads 110 may include a conductive pad in contact with the body 105 that makes an electrical circuit with the electrocardiograph.
- Series of leads 110 may be grouped into three sets: limb, augmented limb, and precordial.
- the 12-lead ECG has a total of three limb leads and three augmented limb leads arranged like spokes of a wheel in the coronal plane (vertical) and six precordial leads that lie on the perpendicular transverse plane (horizontal).
- Analog front-end 125 receives the signals from the series of leads 110 and performs analog processing, such as filtering, of the signals.
- Data storage 155 is any device that records information. Data storage may provide a storage medium for the signals includes within device 100 and a place for calculations of processor 130 to be stored.
- Microprocessor 145 may be a computer processor which incorporates the functions of a computer's central processing unit (CPU) on a single integrated circuit (IC), or a few integrated circuits. Microprocessor 145 may be a multipurpose, clock driven, register based, programmable electronic device which accepts digital or binary data as input, processes it according to instructions stored in its memory or data storage 155 , and provides results as output. Microprocessor 145 contains both combinational logic and sequential digital logic.
- Micro controller 150 may be one or more small computers on a single integrated circuit.
- Micro controller 160 may contain one or more CPUs along with memory and programmable input/output peripherals.
- Program memory in the form of Ferroelectric RAM, NOR flash or OTP ROM is also often included on chip, as well as a small amount of RAM.
- Microcontrollers are designed for embedded applications, in contrast to the microprocessors used in personal computers or other general purpose applications consisting of various discrete chips.
- Digital signal processor (DSP) 140 may perform digital signal processing to perform a wide variety of signal processing operations.
- the signals processed in this manner are a sequence of numbers that represent samples of a continuous variable in a domain such as time, space, or frequency.
- Digital signal processing can involve linear or nonlinear operations.
- Nonlinear signal processing is closely related to nonlinear system identification and can be implemented in the time, frequency, and spatio-temporal domains.
- the application of digital computation to signal processing allows for many advantages over analog processing in many applications, such as error detection and correction in transmission as well as data compression.
- DSP is applicable to both streaming data and static (stored) data.
- Medical personnel often rely on the interpretation of signal voltage levels to understand the morphology of an organ, tissue or other biological structure. Medical personnel interpret the signal voltage based on relative height. Currently, each signal voltage can be changed independently from the other signal voltages. Often the signal height may be changed from one signal to another in order to examiner the signal or to observe a desired feature that is visible with increased magnification of the signal, for example. The result is that the medical personnel cannot rely on the signal height to interpret the morphology across different signals.
- the interpretation of signal voltage levels for organ and tissue morphology is often inaccurate when based upon the relative height of the signal voltage.
- the present system allows for the physician to change the relative height of the signal to allow for examination of details of the signals, while maintaining an ability to interpret signal voltage levels absolutely based on color or other secondary mechanism beyond signal height.
- the disclosed system and method provide for faster and more accurate analysis based upon the color of the signal.
- the signal height may change, such as to view, display, or examine details of the signal, while the colors of the display do not.
- the color scale of the signal provides an absolute scaling of the signal regardless of the displayed height.
- FIG. 2 there is illustrated of several plots 200 of the signal voltages, which may be presented on display 170 of FIG. 1 .
- a first plot 210 illustrates the signal voltage across M1-M2.
- the second plot 220 illustrates the signal voltage across R1-R2.
- the third plot 230 illustrates the signal voltage V3.
- any of the electrodes in the ECG may be depicted including RA (right arm), LA (left arm), RL (right leg), LL (left leg), V1 (fourth intercostal space), V2 (fourth intercostal space), V3 (between leads V2 and V4), V4 (fifth intercostal space), V5 (left anterior axillary line) and V6 (midaxillary line).
- the indication 240 of the signals is provided adjacent to the respective plot 200 .
- the voltage levels plotted in the y-axis may be varied in order to highlight, make them viewable on the display, particular aspects of the signal. This may be changed by accessing the scale change 260 . Such a change may allow a signal characteristic, such as the PQRST signal characteristic 212 to be examined and with greater visibility. For example, the depolarization of the atria may be examined in the p-wave, the filling of the ventricles in the PR interval, the QRS complex and depolarization of the ventricles, the beginning of ventricle repolarization in the ST segment, and the T-wave ventricle repolarization.
- a signal characteristic such as the PQRST signal characteristic 212
- the present system also includes an additional scale 250 for indicating global values to allow physicians to analyze the signal voltage based on the additional scale, such as color.
- additional scale 250 may enable comparisons across signals using the additional scale since the heights of the signals may be set differently to enable particular viewing on a feature, such as the PQRST for example.
- This scale 250 allows the analysis to be done faster and more accurately. Scale 250 allows for comparison across certain plots 210 , 220 , 230 , for example, and is not dependent upon the voltage-level y-axis configuration. That is, scale 250 is not affected by scale change 260 .
- Physicians, or other users may define the relevant threshold of scale 250 according to their preferences.
- the system may show signal strength in color and replace the color on the signal.
- Each signal 210 , 220 , 230 may be segmented into colors showing the signal strength for each segment of the signal. While the signal height may be modified for signal height changes in ones of the signals, in order to view portions of features of the respective signals, the displayed color scheme and colors of the signals are more absolute and do not change. This provides physicians and other personnel a better and faster method to analyze signals and compare between the signals via color.
- any number of scaling systems may be used, including, but not limited to grayscale, other single color shade scales, multi-color scales, and the like.
- the positive and negative coloring may be designed to be symmetrical and the color changes from zero outward. Colors may be provided to be more apparent/clear/bright as the intensity increases. Other modifications may allow the user to decide if they want to change the color (hue) or just its brightness or saturation and to allow analysis of the signals more efficiently even by color deficient users, who often can view the brightness/saturation differences.
- FIG. 3 illustrates a depiction of a display screen 300 of the present invention.
- a first plot 310 illustrates the signal voltage across M1-M2.
- the second plot 320 illustrates the signal voltage across R1-R2.
- Other plots are also contemplated within the present invention and the two plots 310 , 320 are illustrative only.
- the voltage levels plotted in the y-axis may be varied in order to highlight plots or certain aspects or otherwise make them viewable on the display.
- the scale may be changed by accessing the scale change 360 . Such a change may allow a signal characteristic, such as the PQRST signal characteristic 312 .
- the present system also includes an additional scale 350 for indicating global values of signal level.
- Scale 350 allows for comparison across certain plots 310 , 320 , for example, and is not dependent upon the voltage-level of the y-axis configuration.
- Scale 370 represents another color scale that is related to the map. This scale 370 may be provided for a different purpose than scale 350 . Scale 370 provides a scale for the LAT value. Further, scale 370 provides information with portion of display 380 . A three-dimensional depiction of the chamber walls of the heart are displayed and related to the ECG measurements. This 3-D depiction includes a representation of the catheters that are in the heart chambers at this point in time. This 3-D depiction provides an image of the heart chamber being mapped. This depiction provides context for the plots 310 , 320 , for example.
- FIG. 4 illustrates a method 400 of display for the device of FIG. 1 .
- Method 400 includes the step of monitoring signals in a device at step 410 .
- method 400 includes displaying signals obtained via the device on a display.
- method 400 includes controlling a first voltage display level to provide display of at least one measured signal with a height designed to examine details of the measured signal.
- Method 400 includes providing a second scale to the entirety of the display independent of the first voltage display level, at step 440 .
- ROM read only memory
- RAM random access memory
- register cache memory
- semiconductor memory devices magnetic media such as internal hard disks and removable disks, magneto-optical media, and optical media such as CD-ROM disks, and digital versatile disks (DVDs).
Abstract
The present system allows for the physician to change the relative height of the signal to allow for examination of details of the signals, while maintaining an ability to interpret signal voltage levels absolutely based on color or other secondary mechanism beyond signal height. The disclosed system and method provide for faster and more accurate analysis based upon the color of the signal. The signal height may change, such as to view, display, or examine details of the signal, while the colors of the display do not. The color scale of the signal provides an absolute scaling of the signal regardless of the displayed height.
Description
- This application is a continuation of the benefit of U.S. Non-Provisional application Ser. No. 15/885,325, filed Jan. 31, 2018, which is incorporated by reference as if fully set forth.
- The present invention relates to presentation of signals for interpretation, and more particularly to presentation of signals for interpretation by medical personnel.
- Medical personnel often rely on the interpretation of signal voltage levels to understand the morphology of an organ, tissue or other biological structure. Medical personnel interpret the signal voltage based on relative height. Currently, each signal voltage can be changed independently from the other signal voltages. The result is that the medical personnel cannot rely on the signal height to interpret the morphology. Therefore, a need exists to provide physicians a way to interpret the signal voltage based on relative height.
- The present system allows for the physician to change the relative height of the signal to allow for examination of details of the signals, while maintaining an ability to interpret signal voltage levels absolutely based on color or other secondary mechanism beyond signal height. The disclosed system and method provide for faster and more accurate analysis based upon the color of the signal. The signal height may change, such as to view, display, or examine details of the signal, while the colors of the display do not. The color scale of the signal provides an absolute scaling of the signal regardless of the displayed height.
- A system and method of for displaying measured signal for a device is disclosed. The system and method include monitoring signals in the device, displaying signals on a display, the signals being at least a subset of the monitored signals, controlling a first voltage display level to provide display of at least one displayed measured signals with a height designed to examine details of the measured signal, and providing a second scale to the entirety of the signals displayed independent of the first voltage display level.
- The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
- A more detailed understanding may be had from the following description, given by way of example in conjunction with the accompanying drawings wherein:
-
FIG. 1 illustrates a block diagram of a device that may be used in conjunction with or provide feedback to the system described herein; -
FIG. 2 illustrates several plots of the signal voltages of the device ofFIG. 2 ; -
FIG. 3 illustrates a depiction of a display screen of the device ofFIG. 1 ; and -
FIG. 4 illustrates a method of display for the device ofFIG. 1 . - In the following description, numerous specific details are set forth, such as particular structures, components, materials, dimensions, processing steps, and techniques, in order to provide a thorough understanding of the present embodiments. However, it will be appreciated by one of ordinary skill of the art that the embodiments may be practiced without these specific details. In other instances, well-known structures or processing steps have not been described in detail in order to avoid obscuring the embodiments. It will be understood that when an element such as a layer, region, or substrate is referred to as being “on” or “over” another element, it can be directly on the other element or intervening elements may also be present. In contrast, when an element is referred to as being “directly on” or “directly” over another element, there are no intervening elements present. It will also be understood that when an element is referred to as being “beneath,” “below,” or “under” another element, it can be directly beneath or under the other element, or intervening elements may be present. In contrast, when an element is referred to as being “directly beneath” or “directly under” another element, there are no intervening elements present.
- In the interest of not obscuring the presentation of embodiments in the following detailed description, some structures, components, materials, dimensions, processing steps, and techniques that are known in the art may have been combined together for presentation and for illustration purposes and in some instances may have not been described in detail. In other instances, some structures, components, materials, dimensions, processing steps and techniques that are known in the art may not be described at all. It should be understood that the following description is rather focused on the distinctive features or elements of various embodiments described herein.
- Cardiac electrophysiology is the science of elucidating, diagnosing, and treating the electrical activities of the heart. One medical system that is used in this area is the CARTO system. In certain procedures, cardiac electrophysiology may be used to treat arrhythmias by ablating tissue surrounding the heart that is either the source of unwanted beats or conducts unwanted signals. After treatment, the ablation results in a denaturing of the tissue preventing the tissue from conducting the unwanted signals or beats.
- Electrocardiography, referred to herein as ECG, and may also be referred to as EKG, is the process of recording the electrical activity of the heart over a period of time using electrodes placed on the skin, or inside the heart using a specialized catheter (i.e. intracardiac ECG). These electrodes detect the small electrical changes that arise from the cardiac muscle's electro-physiologic pattern of depolarizing during each heartbeat. ECGs are commonly or routinely performed cardiology tests. The machine used in the test is an electrocardiograph and the initial output is an electrocardiogram. For the sake of brevity, electrocardiography, electrocardiograph, and electrocardiogram are all referred to herein as ECG, and may also be referred to as EKG.
- An intracardiac electrogram (ICEG) is an ECG with some added intracardiac leads (i.e., inside the heart). Such an ICEG may be utilized in combination with, or in the alternative to, a conventional 12-lead ECG. In a conventional 12-lead ECG, 10 electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the electrical potential of the heart is then measured from 12 different angles (“leads”) and is recorded over a period of time. The procedure duration may vary from tens of minutes to several hours. During each procedure, there are usually several dozens of ablation sessions, each of which may last several seconds up to approximately 1 minute, for example. By way of example, a conventional 12-lead ECG may be performed over a period of time, such as 10 seconds, for example. In this way, the overall magnitude and direction of the electrical depolarization of the heart is captured at each moment throughout the cardiac cycle. A graph of voltage versus time produced by this medical procedure is referred to as an electrocardiogram.
- During each heartbeat, a healthy heart has an orderly progression of depolarization. This orderly pattern of depolarization gives rise to the characteristic ECG tracing. To the trained clinician, an ECG conveys a large amount of information about the structure of the heart and the function of its electrical conduction system. Among other things, an ECG can be used to measure the rate and rhythm of heartbeats, the size and position of the heart chambers, the presence of any damage to the muscle cells or conduction system of the heart, the effects of cardiac drugs, and the function of implanted pacemakers. Interpretation of the ECG is fundamentally about understanding the electrical conduction system of the heart. Normal conduction starts and propagates in a predictable pattern, and deviation from this pattern can be a normal variation or be pathological.
- As set forth above, cardiac electrophysiology is the science of diagnosing and treating the electrical activities of the heart using, among other techniques, the ECG. The term is usually used to describe studies of such phenomena by invasive (intracardiac) catheter recording of spontaneous activity as well as of cardiac responses to programmed electrical stimulation (PES). These studies are performed to assess complex arrhythmias, elucidate symptoms, evaluate abnormal electrocardiograms, assess risk of developing arrhythmias in the future, and design treatment. Therapeutic methods include ablations. Ablation generally refers to the removal, killing or scarring of biological tissue, such as to alter the contraction patterns, usually by surgery, and may include methods of ablating aberrant tissue from within the body via minimally invasive procedures. In cardiac electrophysiology procedures, the dysfunctional tissue may be ablated using heat generated from alternating electric current at radio frequencies in the range of 350-500 kHz. As part of the ablation procedure, the ablation electrode, used in ablating the tissue, may be monitored for temperature as compared to a maximum or target temperature and once the temperature is reached, power may be switched to another of the electrode within the multi-electrode system.
-
FIG. 1 illustrates a block diagram of adevice 100 that may be used in conjunction with or provide feedback to the system described herein.Device 100 may take the form of an ECG.Device 100 includes a series ofleads 110 that taper into a single multiplexedinput 115. The series ofleads 110 may be placed on ahuman test subject 105. Additional leads 107, which may be included with series ofleads 110, or separate therefrom (as shown) may be intracardiac leads 107. - Intracardiac leads 107 may be used for diagnostic or therapeutic treatment, such as for mapping electrical potentials in a
heart 126 of apatient 105. Alternatively, intracardiac leads 107 may be used, mutatis mutandis, for other therapeutic and/or diagnostic purposes in the heart or in other body organs. - Intracardiac leads 107 may be inserted in the vascular system of the
patient 105 so that adistal end 132 of theleads 107 enters a chamber of the patient'sheart 126. AlthoughFIG. 1 shows asingle lead 107 with a single location sensor, embodiments of the present invention may utilize probes with more than one location sensor. - The signals on the series of
leads 110 are input into an analog front-end 125 via aninput multiplexor 120. The analog front-end 125 provides to and is controlled by aprocessor 130.Processor 130 may include, as shown, avideo controller 135,digital signal processor 140, amicroprocessor 145, and amicro controller 150.Processor 130 is coupled to adata storage 155. Data ports andprinters 160 may be coupled toprocessor 130. Other input/output devices 165 may be coupled toprocessor 130. Adisplay 170 may be used to provide output of the signals of the ECG. A power/battery management system 175 may be included to provide power fordevice 100 to operate. - Series of
leads 110 includes both the generally used forms of electrodes and leads. One or more of the series ofleads 110 may include an ablation electrode the details of which will be described in more detail herein. The series ofleads 110 may include a conductive pad in contact with thebody 105 that makes an electrical circuit with the electrocardiograph. On a standard 12-lead ECG there are only 10 leads 110. Series ofleads 110 may be grouped into three sets: limb, augmented limb, and precordial. Generally, the 12-lead ECG has a total of three limb leads and three augmented limb leads arranged like spokes of a wheel in the coronal plane (vertical) and six precordial leads that lie on the perpendicular transverse plane (horizontal). - Analog front-
end 125 receives the signals from the series ofleads 110 and performs analog processing, such as filtering, of the signals. -
Data storage 155 is any device that records information. Data storage may provide a storage medium for the signals includes withindevice 100 and a place for calculations ofprocessor 130 to be stored. -
Microprocessor 145 may be a computer processor which incorporates the functions of a computer's central processing unit (CPU) on a single integrated circuit (IC), or a few integrated circuits.Microprocessor 145 may be a multipurpose, clock driven, register based, programmable electronic device which accepts digital or binary data as input, processes it according to instructions stored in its memory ordata storage 155, and provides results as output.Microprocessor 145 contains both combinational logic and sequential digital logic. -
Micro controller 150 may be one or more small computers on a single integrated circuit.Micro controller 160 may contain one or more CPUs along with memory and programmable input/output peripherals. Program memory in the form of Ferroelectric RAM, NOR flash or OTP ROM is also often included on chip, as well as a small amount of RAM. Microcontrollers are designed for embedded applications, in contrast to the microprocessors used in personal computers or other general purpose applications consisting of various discrete chips. - Digital signal processor (DSP) 140 may perform digital signal processing to perform a wide variety of signal processing operations. The signals processed in this manner are a sequence of numbers that represent samples of a continuous variable in a domain such as time, space, or frequency. Digital signal processing can involve linear or nonlinear operations. Nonlinear signal processing is closely related to nonlinear system identification and can be implemented in the time, frequency, and spatio-temporal domains. The application of digital computation to signal processing allows for many advantages over analog processing in many applications, such as error detection and correction in transmission as well as data compression. DSP is applicable to both streaming data and static (stored) data.
- Medical personnel often rely on the interpretation of signal voltage levels to understand the morphology of an organ, tissue or other biological structure. Medical personnel interpret the signal voltage based on relative height. Currently, each signal voltage can be changed independently from the other signal voltages. Often the signal height may be changed from one signal to another in order to examiner the signal or to observe a desired feature that is visible with increased magnification of the signal, for example. The result is that the medical personnel cannot rely on the signal height to interpret the morphology across different signals.
- The interpretation of signal voltage levels for organ and tissue morphology is often inaccurate when based upon the relative height of the signal voltage. The present system allows for the physician to change the relative height of the signal to allow for examination of details of the signals, while maintaining an ability to interpret signal voltage levels absolutely based on color or other secondary mechanism beyond signal height. The disclosed system and method provide for faster and more accurate analysis based upon the color of the signal. The signal height may change, such as to view, display, or examine details of the signal, while the colors of the display do not. The color scale of the signal provides an absolute scaling of the signal regardless of the displayed height.
- Referring now to
FIG. 2 , there is illustrated ofseveral plots 200 of the signal voltages, which may be presented ondisplay 170 ofFIG. 1 . Afirst plot 210 illustrates the signal voltage across M1-M2. Thesecond plot 220 illustrates the signal voltage across R1-R2. Thethird plot 230 illustrates the signal voltage V3. While the particular signals depicted inplots 200 are exemplary, any of the electrodes in the ECG may be depicted including RA (right arm), LA (left arm), RL (right leg), LL (left leg), V1 (fourth intercostal space), V2 (fourth intercostal space), V3 (between leads V2 and V4), V4 (fifth intercostal space), V5 (left anterior axillary line) and V6 (midaxillary line). Theindication 240 of the signals is provided adjacent to therespective plot 200. - As illustrated, the voltage levels plotted in the y-axis may be varied in order to highlight, make them viewable on the display, particular aspects of the signal. This may be changed by accessing the
scale change 260. Such a change may allow a signal characteristic, such as the PQRST signal characteristic 212 to be examined and with greater visibility. For example, the depolarization of the atria may be examined in the p-wave, the filling of the ventricles in the PR interval, the QRS complex and depolarization of the ventricles, the beginning of ventricle repolarization in the ST segment, and the T-wave ventricle repolarization. - In addition to the voltage level plot of height in the y-axis, which may be adjusted on a per plot level, the present system also includes an
additional scale 250 for indicating global values to allow physicians to analyze the signal voltage based on the additional scale, such as color. Such a scale may enable comparisons across signals using the additional scale since the heights of the signals may be set differently to enable particular viewing on a feature, such as the PQRST for example. Thisscale 250 allows the analysis to be done faster and more accurately.Scale 250 allows for comparison acrosscertain plots scale 250 is not affected byscale change 260. - Physicians, or other users, may define the relevant threshold of
scale 250 according to their preferences. In particular, the system may show signal strength in color and replace the color on the signal. Eachsignal - In providing
scale 250, any number of scaling systems may be used, including, but not limited to grayscale, other single color shade scales, multi-color scales, and the like. In providingscale 250, the positive and negative coloring may be designed to be symmetrical and the color changes from zero outward. Colors may be provided to be more apparent/clear/bright as the intensity increases. Other modifications may allow the user to decide if they want to change the color (hue) or just its brightness or saturation and to allow analysis of the signals more efficiently even by color deficient users, who often can view the brightness/saturation differences. -
FIG. 3 illustrates a depiction of adisplay screen 300 of the present invention. Afirst plot 310 illustrates the signal voltage across M1-M2. Thesecond plot 320 illustrates the signal voltage across R1-R2. Other plots are also contemplated within the present invention and the twoplots scale change 360. Such a change may allow a signal characteristic, such as thePQRST signal characteristic 312. - In addition to the voltage level plot of height in the y-axis, which may be adjusted on a per plot level, the present system also includes an
additional scale 350 for indicating global values of signal level.Scale 350 allows for comparison acrosscertain plots - Scale 370 represents another color scale that is related to the map. This scale 370 may be provided for a different purpose than
scale 350. Scale 370 provides a scale for the LAT value. Further, scale 370 provides information with portion ofdisplay 380. A three-dimensional depiction of the chamber walls of the heart are displayed and related to the ECG measurements. This 3-D depiction includes a representation of the catheters that are in the heart chambers at this point in time. This 3-D depiction provides an image of the heart chamber being mapped. This depiction provides context for theplots -
FIG. 4 illustrates amethod 400 of display for the device ofFIG. 1 .Method 400 includes the step of monitoring signals in a device atstep 410. Atstep 420,method 400 includes displaying signals obtained via the device on a display. Atstep 430,method 400 includes controlling a first voltage display level to provide display of at least one measured signal with a height designed to examine details of the measured signal.Method 400 includes providing a second scale to the entirety of the display independent of the first voltage display level, atstep 440. - Although features and elements are described above in particular combinations, one of ordinary skill in the art will appreciate that each feature or element can be used alone or in any combination with or without the other features and elements. In addition, the methods described herein may be implemented in a computer program, software, or firmware incorporated in a computer-readable medium for execution by a computer or processor. Examples of computer-readable media include electronic signals (transmitted over wired or wireless connections) and computer-readable storage media. Examples of computer-readable storage media include, but are not limited to, a read only memory (ROM), a random access memory (RAM), a register, cache memory, semiconductor memory devices, magnetic media such as internal hard disks and removable disks, magneto-optical media, and optical media such as CD-ROM disks, and digital versatile disks (DVDs).
Claims (18)
1. A method of display of a plurality of measured signals, the method comprising:
receiving inputs indicative of the plurality of measured signals;
processing the received inputs to determine a plurality of values, each value of the plurality of values corresponding to one of the plurality of measured signals;
displaying one or more of the plurality of values on a display utilizing a first scale that is absolute to the displayed one or more of the plurality of values;
providing a control of a second scale for a first of the one or more of the plurality of values; and
displaying the first of the one or more of the plurality of values in accordance with the controlled second scale while maintaining the display utilizing the first scale.
2. The method of claim 1 wherein the first scale is provided in color.
3. The method of claim 1 wherein the control of the second scale is independent of the first scale.
4. The method of claim 1 wherein the control of the second scale allows for visual examination on the display of the first of the one or more of the plurality of values.
5. The method of claim 1 wherein the first scale allows for direct comparison across ones of the one or more of the plurality of values.
6. The method of claim 1 wherein the received inputs are from an electrocardiograph (ECG).
7. A display of a plurality of measured signals comprising:
an input for receiving a plurality of values for display, wherein the plurality of valuers are determined from processing a plurality of measured signals from a measurement system, each value of the plurality of values corresponding to one of the plurality of measured signals;
displaying one or more of the plurality of values on a display utilizing a first scale that is absolute to the displayed one or more of the plurality of values;
providing a control of a second scale for a first of the one or more of the plurality of values; and
displaying the first of the one or more of the plurality of values in accordance with the controlled second scale while maintaining the display utilizing the first scale.
8. The display of claim 7 wherein the first scale is provided in color.
9. The display of claim 7 wherein the control of the second scale is independent of the first scale.
10. The display of claim 7 wherein the control of the second scale allows for visual examination on the display of the first of the one or more of the plurality of values.
11. The display of claim 7 wherein the first scale allows for direct comparison across ones of the one or more of the plurality of values.
12. The display of claim 7 wherein the measurement system is an electrocardiograph (ECG).
13. A system for measuring and displaying a signal of interest, the system comprising:
a plurality of sensors for sensing and outputting a plurality of measured signals;
an input/out unit for receiving the plurality of measured signals from the plurality of sensors;
a processor for processing the received plurality of measured signals to determine a plurality of values, each value of the plurality of values corresponding to one of the plurality of measured signals;
a display for displaying one or more of the plurality of values on a display utilizing a first scale that is absolute to the displayed one or more of the plurality of values;
the display further providing a control of a second scale for a first of the one or more of the plurality of values; and
the display further displaying the first of the one or more of the plurality of values in accordance with the controlled second scale while maintaining the display utilizing the first scale.
14. The system of claim 13 wherein the first scale is provided in color.
15. The system of claim 13 wherein the control of the second scale is independent of the first scale.
16. The system of claim 13 wherein the control of the second scale allows for visual examination on the display of the first of the one or more of the plurality of values.
17. The system of claim 13 wherein the first scale allows for direct comparison across ones of the one or more of the plurality of values.
18. The system of claim 13 wherein the measurement system is an electrocardiograph (ECG).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/468,296 US20210401348A1 (en) | 2018-01-31 | 2021-09-07 | Signal color morphology |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/885,325 US11109792B2 (en) | 2018-01-31 | 2018-01-31 | Signal color morphology |
US17/468,296 US20210401348A1 (en) | 2018-01-31 | 2021-09-07 | Signal color morphology |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/885,325 Continuation US11109792B2 (en) | 2018-01-31 | 2018-01-31 | Signal color morphology |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210401348A1 true US20210401348A1 (en) | 2021-12-30 |
Family
ID=65268808
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/885,325 Active 2038-09-17 US11109792B2 (en) | 2018-01-31 | 2018-01-31 | Signal color morphology |
US17/468,296 Pending US20210401348A1 (en) | 2018-01-31 | 2021-09-07 | Signal color morphology |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/885,325 Active 2038-09-17 US11109792B2 (en) | 2018-01-31 | 2018-01-31 | Signal color morphology |
Country Status (7)
Country | Link |
---|---|
US (2) | US11109792B2 (en) |
EP (1) | EP3520693A1 (en) |
JP (1) | JP7263030B2 (en) |
CN (1) | CN110090011A (en) |
AU (1) | AU2019200480A1 (en) |
CA (1) | CA3031976A1 (en) |
IL (1) | IL264429B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11432754B2 (en) * | 2019-09-24 | 2022-09-06 | Biosense Webster (Israel) Ltd. | Intracardiac electrocardiogram presentation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110021936A1 (en) * | 2009-07-24 | 2011-01-27 | Shen Luo | Medical data display with 3-D and 2-D color mapping |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3043981B2 (en) | 1995-12-26 | 2000-05-22 | 健一 森田 | Active oxygen generating agent and active oxygen generating method using the same |
US5777598A (en) * | 1996-12-30 | 1998-07-07 | Honeywell Inc. | Computer-generated display permitting alignment of one scale of each of a plurality of graphs |
US5782773A (en) | 1997-05-05 | 1998-07-21 | Chih-Wei Chen | Three-dimensional electrocardiogram display method |
US6741887B1 (en) * | 2000-12-01 | 2004-05-25 | Ge Medical Systems Information Technologies, Inc. | Apparatus and method for presenting periodic data |
US6778852B2 (en) * | 2002-03-14 | 2004-08-17 | Inovise Medical, Inc. | Color-coded ECG |
US20040054294A1 (en) * | 2002-09-18 | 2004-03-18 | Ramseth Douglas J. | Method and apparatus for interactive annotation and measurement of time series data with centralized analysis and review |
WO2006044868A1 (en) | 2004-10-20 | 2006-04-27 | Nervonix, Inc. | An active electrode, bio-impedance based, tissue discrimination system and methods and use |
US7751874B2 (en) * | 2005-04-25 | 2010-07-06 | Charles Olson | Display for ECG diagnostics |
EP1885240B1 (en) | 2005-05-17 | 2016-02-03 | Bio Signal Analysis ltd. | Analysis of electrocardiogram signals |
US7831076B2 (en) | 2006-12-08 | 2010-11-09 | Biosense Webster, Inc. | Coloring electroanatomical maps to indicate ultrasound data acquisition |
US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
US9101333B2 (en) | 2011-11-14 | 2015-08-11 | Biosense Webster (Israel) Ltd. | Integrative atrial fibrillation ablation |
US20130138003A1 (en) * | 2011-11-30 | 2013-05-30 | General Electric Company | Method, apparatus and computer program product for monitoring clinical state of a subject |
WO2014160090A2 (en) * | 2013-03-13 | 2014-10-02 | Medstar Health | Electrocardiograph display by anatomical structure |
US9414787B2 (en) * | 2013-11-21 | 2016-08-16 | Welch Allyn, Inc. | Navigation features for electrocardiograph device user interface |
US10506939B2 (en) * | 2015-08-11 | 2019-12-17 | Biosense Webster (Israel) Ltd. | Matching and tracking time sequences of heart activation |
-
2018
- 2018-01-31 US US15/885,325 patent/US11109792B2/en active Active
-
2019
- 2019-01-23 IL IL264429A patent/IL264429B/en unknown
- 2019-01-24 AU AU2019200480A patent/AU2019200480A1/en not_active Abandoned
- 2019-01-30 JP JP2019014034A patent/JP7263030B2/en active Active
- 2019-01-30 EP EP19154496.4A patent/EP3520693A1/en active Pending
- 2019-01-30 CA CA3031976A patent/CA3031976A1/en not_active Abandoned
- 2019-01-31 CN CN201910102971.XA patent/CN110090011A/en active Pending
-
2021
- 2021-09-07 US US17/468,296 patent/US20210401348A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110021936A1 (en) * | 2009-07-24 | 2011-01-27 | Shen Luo | Medical data display with 3-D and 2-D color mapping |
Also Published As
Publication number | Publication date |
---|---|
JP7263030B2 (en) | 2023-04-24 |
EP3520693A1 (en) | 2019-08-07 |
AU2019200480A1 (en) | 2019-08-15 |
IL264429A (en) | 2019-05-30 |
JP2019130311A (en) | 2019-08-08 |
CA3031976A1 (en) | 2019-07-30 |
US20190231209A1 (en) | 2019-08-01 |
US11109792B2 (en) | 2021-09-07 |
IL264429B (en) | 2022-01-01 |
CN110090011A (en) | 2019-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210401348A1 (en) | Signal color morphology | |
EP3845127A1 (en) | Methods and systems for estimation of residual ecg noise level and adaptive noise threshold | |
US20220369989A1 (en) | Impedance measurements using burst pulses to prevent noise on ecg | |
US10993666B2 (en) | Middle point zero reference | |
CN108968944B (en) | Cardiac electrophysiology machine including catheter stability while estimating impedance drop | |
CN111657913B (en) | Midfield signal extraction | |
Kossick et al. | PhD" Linda Hill, DNP"(" DNS, Union University, Jackson, TN, USA:" University of Alabama at Birmingham, Birmingham, AL, USA;“University | |
JP2021058423A (en) | Diagnosis assisting system and diagnosis assisting method | |
Trobec et al. | Body surface mapping after partial left ventriculotomy | |
CN111297471A (en) | Display of arrhythmia type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: BIOSENSE WEBSTER (ISRAEL) LTD., ISRAEL Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BAR-TAL, MEIR;INGEL, MOSHE;SIGNING DATES FROM 20180214 TO 20180307;REEL/FRAME:063616/0525 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |